Pharma Journalist -

SMi reports: Invitations from the conference co-chairs has been released for the upcoming Pain Therapeutics conference in May this year. On the 13th and 14th May 2019 in London, SMi…
Read More...

The 4th annual Pre-filled Syringes West Coast conference and exhibition is returning to San Diego, USA, on June 3rd – 4th 2019. SMi Group are delighted to have Michael Song, Senior…
Read More...

Amgen, Cytokinetics, Incorporated and Servier today announced that METEORIC-HF (Multicenter Exercise Tolerance Evaluation of Omecamtiv Mecarbil Related to Increased Contractility in…
Read More...

Urovant Sciences announced it has entered into a debt financing agreement with Hercules Capital for up to $100 million. Urovant plans to use the proceeds to fund ongoing development of…
Read More...

Ipsen and Clementia Pharmaceuticals announced that they have entered into an agreement for Ipsen to acquire Clementia Pharmaceuticals, including its key late-stage clinical asset…
Read More...

Novartis announced that it is exercising its option to license the rights to develop and commercialize TQJ230, an investigational agent previously known as AKCEA-APO(a)-LRx, from Akcea…
Read More...

The Phase III THEMIS trial met its primary endpoint and demonstrated that Brilinta (ticagrelor), taken in conjunction with aspirin, showed a statistically-significant reduction in a…
Read More...

AbbVie and Voyager Therapeutics announced an exclusive, global strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed at pathological…
Read More...

Mallinckrodt Pharmaceuticals announced it has entered into a research collaboration agreement with Transimmune AG, a company developing novel immunotherapies based on its unique…
Read More...

Titan Pharmaceuticals announced the execution of a specialty pharmacy distribution and services agreement with AllianceRx Walgreens Prime that will expand patient access to treatment…
Read More...